ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,380.00
-9.45 (-0.68%)
BSENSE

Aug 07, 02:25 PM

BSE+NSE Vol: 29.01 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
-0.68%
-0.63%
1W
2.01%
0.46%
1M
-3.94%
0.35%
YTD
-8.23%
-7.94%
1Y
-18.56%
-2.69%
3Y
67.3%
18.95%
5Y
84.5%
44.54%
10Y
%
179.41%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.52%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.26%
0.52%
0.26%
6 Months
-3.64%
0.49%
-3.15%
1 Year
-18.56%
0.43%
-18.13%
2 Years
23.18%
1.22%
24.4%
3 Years
67.3%
1.74%
69.04%
4 Years
99.57%
2.10%
101.67%
5 Years
84.5%
2.89%
87.39%

Latest dividend: 7.21 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-3.16%
3
Quartile
quartile-3
Mar-Jun
10.52%
2
Quartile
quartile-2
Dec-Mar
-13.67%
4
Quartile
quartile-4
YTD
-18%
2
Quartile
quartile-2
2025
9.4%
2
Quartile
quartile-2
2024
50.95%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-3.16%
4
Quartile
quartile-4
Mar-Jun
10.52%
2
Quartile
quartile-2
Dec-Mar
-13.67%
3
Quartile
quartile-3
YTD
-18%
1
Quartile
quartile-1
2025
9.4%
2
Quartile
quartile-2
2024
50.95%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-3.16%
4
Quartile
quartile-4
Mar-Jun
10.52%
2
Quartile
quartile-2
Dec-Mar
-13.67%
3
Quartile
quartile-3
YTD
-18%
2
Quartile
quartile-2
2025
9.4%
2
Quartile
quartile-2
2024
50.95%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available